Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Hum Vaccin Immunother ; 10(8): 2387-94, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25424946

RESUMO

Patients with hematological malignancies have high risk for morbidity and mortality from influenza. This study was conducted to evaluate the immunogenicity and reactogenicity of an influenza A(H1N1)pdm09 vaccine among such subjects. Fifty subjects were vaccinated twice during the 2009-2010 season. The antibody response was expressed in terms of mean fold rise (MFR) of geometric mean titer, seroresponse proportion (sR), and seroprotection proportion (sP). The first vaccination induced only a small response, and additional antibody was acquired after the second dose (MFR 2.3 and 3.9, sR 32% and 54%, and sP 30% and 48% after the first and the second vaccination, respectively). Rituximab treatment showed an especially inhibitory effect (MFR 1.3, sR 9% and sP 0%). When analyzed using logistic regression models, only rituximab was found to have an independent effect; the adjusted odds ratio for sR was 0.09 (P = 0.05). Influenza vaccination of patients with hematological malignancies resulted in adepuate response, and the second vaccination induced additional antibody. It is therefore recommended to vaccinate this group twice.


Assuntos
Neoplasias Hematológicas/complicações , Vírus da Influenza A Subtipo H1N1/imunologia , Vacinas contra Influenza/administração & dosagem , Vacinas contra Influenza/imunologia , Influenza Humana/prevenção & controle , Adulto , Idoso , Idoso de 80 Anos ou mais , Anticorpos Monoclonais Murinos/uso terapêutico , Anticorpos Antivirais/sangue , Feminino , Humanos , Fatores Imunológicos/uso terapêutico , Vacinas contra Influenza/efeitos adversos , Influenza Humana/virologia , Masculino , Pessoa de Meia-Idade , Rituximab , Adulto Jovem
2.
Rinsho Byori ; 60(7): 677-82, 2012 Jul.
Artigo em Japonês | MEDLINE | ID: mdl-22973730

RESUMO

St. Mary's Hospital Medical Inspecting Center acquired ISO 15189 authorization in December, 2007. In the process of authorization acquisition, measures were taken to improve various quality issues, and a marked effect was seen in patient services and medical safety control. Furthermore, we tried to improve ward nursing management using ISO, drew up standard operating procedures through detailed job analysis, and enabled ward operation standardization. In this paper, while describing the effect of ISO 15189 on clinical examinations, we refer to the significance of improving quality of hospital management which our clinical laboratory lead to.


Assuntos
Acreditação/normas , Laboratórios Hospitalares/normas , Controle de Qualidade , Gestão da Qualidade Total , Hospitais Privados , Setor Privado , Qualidade da Assistência à Saúde
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA